Martina Gobec

1.2k total citations
55 papers, 845 citations indexed

About

Martina Gobec is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Martina Gobec has authored 55 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 18 papers in Immunology and 16 papers in Oncology. Recurrent topics in Martina Gobec's work include Peptidase Inhibition and Analysis (13 papers), Ubiquitin and proteasome pathways (12 papers) and Immune Response and Inflammation (10 papers). Martina Gobec is often cited by papers focused on Peptidase Inhibition and Analysis (13 papers), Ubiquitin and proteasome pathways (12 papers) and Immune Response and Inflammation (10 papers). Martina Gobec collaborates with scholars based in Slovenia, Germany and Netherlands. Martina Gobec's co-authors include Irena Mlinarič‐Raščan, Žiga Jakopin, Marija Sollner Dolenc, Tihomir Tomašič, Izidor Sosič, Stanislav Gobec, Marko Anderluh, Katra Kolšek, Iztok Turel and Jakob Kljun and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Chemical Communications.

In The Last Decade

Martina Gobec

49 papers receiving 841 citations

Peers

Countries citing papers authored by Martina Gobec

Since Specialization

Citations

This map shows the geographic impact of Martina Gobec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Gobec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Gobec more than expected).

Fields of papers citing papers by Martina Gobec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Gobec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Gobec. The network helps show where Martina Gobec may publish in the future.

Co-authorship network of co-authors of Martina Gobec

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Gobec. A scholar is included among the top collaborators of Martina Gobec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Gobec. Martina Gobec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	α-Aminoboronic Acid Moieties in Boro Dipeptides Modulate Proteasome Subunit Selectivity and Provide Access to Compounds with Potent Anticancer and Anti-Inflammatory Activity 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Stane Pajk, Stanislav Gobec, Zdenko Časar, Martina Gobec, Izidor Sosič	0
2	Adaptive immune cell reactivity to polycaprolactone, alginate, chitosan, and zein nanofibers 2025 ·International Journal of Biological Macromolecules ·(unknown), Špela Zupančič, Martina Gobec, Julijana Kristl, Matjaž Jeras	0
3	Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists 2024 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Federica Santoro, (unknown), Martina Gobec, Jussara Amato, Bruno Pagano, Luciana Marinelli, Alfonso Carotenuto, Gian Cesare Tron, Francesco Saverio Di Leva, Žiga Jakopin, Diego Brancaccio, Mariateresa Giustiniano	2
4	Design, Synthesis, and Evaluation of BCL‐2 Targeting PROTACs 2024 ·Chemistry - A European Journal ·Aleša Bricelj, Yuen Lam Dora Ng, Martina Gobec, Robert D. Kuchta, Wanyi Hu, (unknown), (unknown), Michael Gütschow, Guangrong Zheng, Jan Krönke, Christian Steinebach, Izidor Sosič	3
5	New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer 2024 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Asta Zubrienė, Ana Mitrović, Simona Golič Grdadolnik, Martina Gobec, Tihomir Tomašič	9
6	Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L 2024 ·Seminars in Thrombosis and Hemostasis ·Gerd Bendas, Martina Gobec, Martin Schlesinger	1
7	Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening 2022 ·Molecules ·(unknown), Tihomir Tomašič, (unknown), (unknown), (unknown), Martina Gobec, Matthew G. Alteen, David J. Vocadlo, Roland J. Pieters, Marko Anderluh	5
8	Targeting the deubiquitinase USP7 for degradation with PROTACs 2022 ·Chemical Communications ·(unknown), Izidor Sosič, Martina Gobec, (unknown), (unknown), (unknown), (unknown), Michael Gütschow, Jan Krönke, Christian Steinebach	36
9	In Silico Discovery and Optimisation of a Novel Structural Class of Hsp90 C-Terminal Domain Inhibitors 2022 ·Biomolecules ·(unknown), (unknown), Martina Gobec, Tihomir Tomašič	14
10	Halogenated ingredients of household and personal care products as emerging endocrine disruptors 2022 ·Chemosphere ·(unknown), Martina Gobec, Žiga Jakopin	17
11	Structure-Activity Relationships of Benzothiazole-Based Hsp90 C-Terminal-Domain Inhibitors 2021 ·Pharmaceutics ·(unknown), (unknown), Martina Durcik, Lucíja Peterlin Mašič, Martina Gobec, Nace Zidar, Tihomir Tomašič	18
12	Intracellular Hydrolysis of Small-Molecule O-Linked N-Acetylglucosamine Transferase Inhibitors Differs among Cells and Is Not Required for Its Inhibition 2020 ·Molecules ·(unknown), (unknown), Stane Pajk, Martina Gobec, Tihomir Tomašič, Roland J. Pieters, Marko Anderluh	6
13	Pyridylethanol(phenylethyl)amines are non-azole, highly selective Candida albicans sterol 14α-demethylase inhibitors 2020 ·Bioorganic Chemistry ·(unknown), (unknown), Izidor Sosič, Martina Gobec, (unknown), Marija Ivanov, Marina Sokóvić, Darko Kocjan, Damjana Rozman, Simona Golič Grdadolnik	8
14	A focused structure–activity relationship study of psoralen-based immunoproteasome inhibitors 2019 ·MedChemComm ·(unknown), Izidor Sosič, (unknown), Janez Mravljak, Irena Mlinarič‐Raščan, Stanislav Gobec, Martina Gobec	10
15	Antioxidant and anti-inflammatory properties of 1,2,4-oxadiazole analogs of resveratrol 2015 ·Chemico-Biological Interactions ·Martina Gobec, Tihomir Tomašič, (unknown), Irena Mlinarič‐Raščan, Marija Sollner Dolenc, Žiga Jakopin	48
16	Chemo-sensitizing effects of EP4 receptor-induced inactivation of nuclear factor-κB 2014 ·European Journal of Pharmacology ·Martina Gobec, (unknown), Jozo Delić, (unknown), Irena Mlinarič‐Raščan	9
17	Novel N-amidinopiperidine-based proteasome inhibitor preserves dendritic cell functionality and rescues their Th1-polarizing capacity in Ramos-conditioned tumor environment 2014 ·Cancer Immunology Immunotherapy ·Urban Švajger, Martina Gobec, Aleš Obreza, Irena Mlinarič‐Raščan	2
18	Molecular docking revealed potential disruptors of glucocorticoid receptor-dependent reporter gene expression 2014 ·Toxicology Letters ·Katra Kolšek, Martina Gobec, Irena Mlinarič‐Raščan, Marija Sollner Dolenc	21
19	Antimicrobial activity and cytotoxicity of some 2-amino-5-alkylidene-thiazol-4-ones 2013 ·Molecular Diversity ·Marko Jukič, Aleksandra Ɖorđević, Jelena Lazarević, Martina Gobec, Andrija Šmelcerović, Marko Anderluh	11
20	Selective Cytotoxicity of Amidinopiperidine Based Compounds Towards Burkitt’s Lymphoma Cells Involves Proteasome Inhibition 2012 ·PLoS ONE ·Martina Gobec, Aleš Obreza, (unknown), Boris Brus, Stanislav Gobec, Irena Mlinarič‐Raščan	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact